Sector
PharmaceuticalsOpen
₹57.5Prev. Close
₹57.15Turnover(Lac.)
₹2.14Day's High
₹59.85Day's Low
₹57.552 Week's High
₹8552 Week's Low
₹54Book Value
₹42.28Face Value
₹10Mkt Cap (₹ Cr.)
56.12P/E
37.6EPS
1.52Divi. Yield
1.44 Nov 2024
12:00 AM
Board Meeting
Agenda : Audited Result
12 Aug 2024
12:00 AM
BookCloser
12 Aug 2024
12:00 AM
Dividend
Dividend Amount: 0.8
12 Aug 2024
12:00 AM
AGM
Announcement Date: 12 Aug, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 9.66 | 9.66 | 9.25 | 8.82 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 30.93 | 29.58 | 27.22 | 24.67 |
Net Worth | 40.59 | 39.24 | 36.47 | 33.49 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 58.75 | 48.36 | 49.01 | 42.82 |
yoy growth (%) | 21.47 | -1.32 | 14.45 | 4.25 |
Raw materials | -34.5 | -25.11 | -28.39 | -25.63 |
As % of sales | 58.71 | 51.92 | 57.92 | 59.86 |
Employee costs | -8.01 | -6.85 | -5.93 | -5.41 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 1.68 | 0.92 | 0.75 | -0.03 |
Depreciation | -0.55 | -0.55 | -0.6 | -0.86 |
Tax paid | -0.58 | -0.19 | -0.19 | -0.49 |
Working capital | 5.71 | -2.3 | -5.65 | -2.17 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 21.47 | -1.32 | 14.45 | 4.25 |
Op profit growth | 48.33 | -40.99 | 33.22 | -36.08 |
EBIT growth | 32.42 | -31.72 | 36.55 | -38.08 |
Net profit growth | 51.66 | 28.27 | -226.4 | -182.58 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|
Gross Sales | 67.28 | 65.35 | 65.5 |
Excise Duty | 0 | 0 | 0 |
Net Sales | 67.28 | 65.35 | 65.5 |
Other Operating Income | 0 | 0 | 0 |
Other Income | 0.42 | 0.33 | 0.08 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,808.2 | 157.37 | 4,33,847.75 | 863.29 | 0.75 | 5,123.67 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,250.2 | 90.32 | 1,65,923.17 | 518 | 0.48 | 2,302 | 513.62 |
Cipla Ltd CIPLA | 1,508.1 | 28.77 | 1,21,796.04 | 1,178.16 | 0.86 | 3,969.86 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,338.4 | 69.06 | 1,12,981.55 | 460 | 0.84 | 2,376 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,615.3 | 52.27 | 1,04,785.17 | 634.43 | 0 | 2,529.74 | 269.23 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non-Exec. & Independent Dir.
Dilip R Salgaocar
Non-Exec. & Independent Dir.
Krishna B Deshpande
Non-Exec. & Independent Dir.
Madan Laxman Kapre
Chairman & Independent Directo
K Vinay Kumar
Non-Exec & Non-Independent Dir
Shashank B Sandu
Managing Director
Umesh B Sandu
Non-Exec & Non-Independent Dir
Shubhada P Sandu
Company Sec. & Compli. Officer
Pratika Mhambray
Non Executive Director
Vijay Kottapalli
Non Executive Director
Jayshree Sandu
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Sandu Pharmaceuticals Ltd
Summary
Sandu Pharmaceuticals Ltd (SPL) was established in 1985. The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU.SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations. This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards. Ayurvedic products have a very good market in India and abroad due to their minimal side effects.The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97. Thereafter, it commenced production of manufacturing Unit II in Goa from May, 2002.
Read More
What is the Sandu Pharmaceuticals Ltd share price today?
The Sandu Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹58.09 today.
What is the Market Cap of Sandu Pharmaceuticals Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sandu Pharmaceuticals Ltd is ₹56.12 Cr. as of 03 Dec ‘24
What is the PE and PB ratio of Sandu Pharmaceuticals Ltd?
The PE and PB ratios of Sandu Pharmaceuticals Ltd is 37.6 and 1.35 as of 03 Dec ‘24
What is the 52 Week High and Low of Sandu Pharmaceuticals Ltd?
The 52-week high/low is the highest and lowest price at which a Sandu Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Sandu Pharmaceuticals Ltd is ₹54 and ₹85 as of 03 Dec ‘24
What is the CAGR of Sandu Pharmaceuticals Ltd?
Sandu Pharmaceuticals Ltd's CAGR for 5 Years at 29.82%, 3 Years at 8.49%, 1 Year at -15.21%, 6 Month at -1.79%, 3 Month at -5.55% and 1 Month at 2.62%.
What is the shareholding pattern of Sandu Pharmaceuticals Ltd?
The shareholding pattern of Sandu Pharmaceuticals Ltd is as follows:
Promoters - 42.90 %
Institutions - 0.01 %
Public - 57.09 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
